Hypothesis

Moderate daily time‑restricted eating (TRE) with a 14‑16 hour fast optimizes mitochondrial quality control by synchronizing feeding‑driven AMPK activation and circadian NAD⁺‑SIRT3 signaling, thereby promoting balanced biogenesis and mitophagy. In contrast, repeated 48‑hour fasts provoke a chronic stress state that suppresses mTORC1 excessively, elevates mitochondrial ROS, and impairs the autophagic clearance of damaged mitochondria, ultimately increasing cardiovascular risk and lean‑mass loss.

Mechanistic Rationale

• Circadian nutrient sensing: TRE aligns food intake with the active phase, boosting AMP/ATP ratio during the fasting window and activating AMPK, which phosphorylates PGC‑1α and ULK1 to drive mitochondrial biogenesis and initiate mitophagy. This oscillation is reinforced by circadian NAD⁺ peaks that activate SIRT3, a mitochondrial deacetylase that enhances antioxidant enzymes (SOD2) and improves respiratory chain efficiency (1, 3).

• Duration‑dependent stress response: Prolonged 48‑hour fasts extend AMPK activation beyond a physiological threshold, leading to sustained inhibition of mTORC1. While acute mTORC1 suppression is beneficial for autophagy, chronic suppression reduces mitochondrial protein synthesis and compromises the replenishment of newly formed organelles, tipping the balance toward net mitochondrial loss (5, 6).

• ROS and inflammasome activation: Extended fasting elevates circulating free fatty acids and induces mitochondrial uncoupling, raising ROS production that can activate the NLRP3 inflammasome and promote endothelial dysfunction—a pathway linked to the 91 % higher cardiovascular mortality observed with very short eating windows (4).

• Lean mass preservation: Moderate TRE preserves lean tissue because the fasting interval is insufficient to trigger profound catabolic signaling, whereas 48‑hour fasts increase ubiquitin‑proteasome activity and myofiber atrophy, exacerbating sarcopenic risk.

Testable Predictions

1. Participants undergoing 14‑16 h TRE for 8 weeks will show a significant increase in mitochondrial respiration (State 3 OXPHOS) and SIRT3 activity in peripheral blood mononuclear cells compared with baseline, whereas those on a 48‑h twice‑weekly protocol will show no change or a decrease.

2. Mitophagy flux, measured by the ratio of mitochondrial LC3‑II to total LC3‑II after lysosomal inhibition, will be elevated in the TRE group but unchanged or reduced in the 48‑h group.

3. Fasting insulin, LDL‑C, and systolic blood pressure will improve similarly in both groups, but the 48‑h group will exhibit higher urinary 8‑iso‑PGF₂α (a marker of oxidative stress) and greater loss of lean mass measured by DXA.

4. Cardiovascular risk scores (e.g., Framingham) will improve in the TRE group and worsen or remain unchanged in the 48‑h group over the intervention period.

Proposed Experimental Design

A randomized, crossover trial with 60 sedentary overweight adults (age 40‑65) will compare two 8‑week interventions separated by a 4‑week washout:

• Arm A: Daily 14‑16 h TRE (e.g., 08:00‑18:00 eating window).
• Arm B: Two non‑consecutive 48‑hour fasts per week with ad libitum feeding on other days.

Outcomes collected at baseline and endpoint:

• Mitochondrial function: high‑resolution respirometry (OXPHOS capacity) and ATP production.
• Molecular markers: Western blot for p‑AMPK, SIRT3, PGC‑1α, LC3‑II, PINK1; ELISA for 8‑iso‑PGF₂α.
• Body composition: DXA for lean and fat mass.
• Clinical metrics: fasting glucose, insulin, lipid panel, blood pressure.

Statistical analysis will use mixed‑effects models with participant as random effect; a priori power calculation assumes a 10 % difference in respiration between groups (α = 0.05, power = 0.8).

Potential Limitations

• Peripheral blood mononuclear cells may not fully reflect tissue‑specific mitochondrial adaptations; future studies could incorporate muscle biopsies.
• Adherence to prolonged fasts may be challenging, potentially introducing bias; objective compliance will be monitored via continuous glucose meters and food logs.
• The 8‑week duration may be insufficient to capture long‑term cardiovascular events; surrogate markers are used accordingly.

Falsifiability: If the 48‑h protocol demonstrates equal or superior improvements in mitochondrial respiration, mitophagy flux, and lean‑mass preservation compared with TRE, the hypothesis would be refuted. Conversely, a lack of any significant difference in oxidative stress or cardiovascular risk markers between groups would also challenge the proposed mechanistic divergence.